MS4A6A is a new prognostic biomarker produced by macrophages in glioma patients

MS4A6A is a new prognostic biomarker produced by macrophages in glioma patients

MS4A6A has been recognized as being associated with aging and the onset of neurodegenerative disease. However, the mechanisms of MS4A6A in glioma biology and prognosis are ill-defined. Here, we show that MS4A6A is upregulated in glioma tissues, resulting in unfavorable clinical outcomes and poor res...

Full description

Bibliographic Details
Main Authors: Chunyu Zhang, Haitao Liu, Yinqiu Tan, Yang Xu, Yuntao Li, Shiao Tong, Sheng Qiu, Qianxue Chen, Zhongzhou Su, Daofeng Tian, Wei Zhou, Chunlong Zhong
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Immunology
Subjects:
glioma
immune microenvironment
prognosis
immunotherapy
indicator
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.865020/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.865020/full

Similar Items